Glenmark Specialty S.A. partners with Lotus to commercialise Ryaltris in key Asian markets
The company will receive an upfront payment as well as regulatory and sales based milestone payments from Lotus
The company will receive an upfront payment as well as regulatory and sales based milestone payments from Lotus
Ram’s appointment follows the launch of the CDI India division in October 2021.
He holds nine US patents and has published in multiple peer-reviewed journals and conferences
The company has 47 ANDA's pending approval with the U.S.FDA
The company has 271 cumulative ANDA filings with USFDA of which 243 ANDAs have been approved and 28 are pending approval
Market data indicates that more than twenty percent of the new chemical entities being developed use roller compaction technology in their development and commercialization
Their strong recommendation is based on moderate certainty evidence that it improves survival and reduces the need for ventilation
Chicago based virtual reality company reaches AIIMS, assisting in surgical planning and training
New data from ongoing trial showed increased antibody response against Beta, Delta, Alpha, Gamma and Omicron variants following third dose booster with Vaxzevria
Nuvaxovid is the first protein-based Covid-19 vaccine granted approval in South Korea
Subscribe To Our Newsletter & Stay Updated